Ameritas Investment Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.7K | Hold |
3,101
| – | – | ﹤0.01% | 1978 |
|
|
2025
Q4 | $83K | Hold |
3,101
| – | – | ﹤0.01% | 1810 |
|
|
2025
Q3 | $82.6K | Sell |
3,101
-661
| -18% | -$17.1K | ﹤0.01% | 1802 |
|
|
2025
Q2 | $86.4K | Hold |
3,762
| – | – | ﹤0.01% | 1853 |
|
|
2025
Q1 | $109K | Hold |
3,762
| – | – | ﹤0.01% | 1644 |
|
|
2024
Q4 | $140K | Hold |
3,762
| – | – | ﹤0.01% | 1555 |
|
|
2024
Q3 | $183K | Sell |
3,762
-225
| -6% | -$9.87K | 0.01% | 1380 |
|
|
2024
Q2 | $159K | Hold |
3,987
| – | – | 0.01% | 1422 |
|
|
2024
Q1 | $175K | Hold |
3,987
| – | – | 0.01% | 1376 |
|
|
2023
Q4 | $247K | Buy |
3,987
+212
| +6% | +$11.1K | 0.01% | 1134 |
|
|
2023
Q3 | $174K | Buy |
3,775
+702
| +23% | +$38.3K | 0.01% | 1271 |
|
|
2023
Q2 | $177K | Hold |
3,073
| – | – | 0.01% | 1214 |
|
|
2023
Q1 | $115K | Hold |
3,073
| – | – | ﹤0.01% | 1449 |
|
|
2022
Q4 | $93.4K | Hold |
3,073
| – | – | ﹤0.01% | 1654 |
|
|
2022
Q3 | $86K | Hold |
3,073
| – | – | ﹤0.01% | 1602 |
|
|
2022
Q2 | $106K | Hold |
3,073
| – | – | ﹤0.01% | 1467 |
|
|
2022
Q1 | $110K | Hold |
3,073
| – | – | ﹤0.01% | 1577 |
|
|
2021
Q4 | $72K | Hold |
3,073
| – | – | ﹤0.01% | 1890 |
|
|
2021
Q3 | $58K | Hold |
3,073
| – | – | ﹤0.01% | 2055 |
|
|
2021
Q2 | $62K | Hold |
3,073
| – | – | ﹤0.01% | 2041 |
|
|
2021
Q1 | $56K | Hold |
3,073
| – | – | ﹤0.01% | 2014 |
|
|
2020
Q4 | $62K | Hold |
3,073
| – | – | ﹤0.01% | 1851 |
|
|
2020
Q3 | $58K | Hold |
3,073
| – | – | ﹤0.01% | 1742 |
|
|
2020
Q2 | $69K | Hold |
3,073
| – | – | ﹤0.01% | 1633 |
|
|
2020
Q1 | $46K | Hold |
3,073
| – | – | ﹤0.01% | 1702 |
|
|
2019
Q4 | $59K | Hold |
3,073
| – | – | ﹤0.01% | 1818 |
|
|
2019
Q3 | $61K | Hold |
3,073
| – | – | ﹤0.01% | 1761 |
|
|
2019
Q2 | $65K | Hold |
3,073
| – | – | ﹤0.01% | 1760 |
|
|
2019
Q1 | $63K | Hold |
3,073
| – | – | ﹤0.01% | 1745 |
|
|
2018
Q4 | $61K | Hold |
3,073
| – | – | ﹤0.01% | 1690 |
|
|
2018
Q3 | $59K | Hold |
3,073
| – | – | ﹤0.01% | 1894 |
|
|
2018
Q2 | $47K | Hold |
3,073
| – | – | ﹤0.01% | 2016 |
|
|
2018
Q1 | $58K | Hold |
3,073
| – | – | ﹤0.01% | 1838 |
|
|
2017
Q4 | $59K | Hold |
3,073
| – | – | ﹤0.01% | 1835 |
|
|
2017
Q3 | $49K | Hold |
3,073
| – | – | ﹤0.01% | 1900 |
|
|
2017
Q2 | $55K | Hold |
3,073
| – | – | ﹤0.01% | 1844 |
|
|
2017
Q1 | $45K | Buy |
+3,073
| New | +$48.3K | ﹤0.01% | 1915 |
|
Other funds holding AMPH
VCM
BTW
Ameritas Investment Partners's AMPH Position: Q1 2026 in Review
Ameritas Investment Partners held its Amphastar Pharmaceuticals (AMPH) position steady in Q1 2026 at 3,101 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.
Ameritas Investment Partners first reported a position in AMPH in Q1 2017 and has held it in 37 quarters since. The position peaked at $247K in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Ameritas Investment Partners held 3,101 shares of Amphastar Pharmaceuticals worth $60.7K as of Q1 2026.
- Ameritas Investment Partners left its Amphastar Pharmaceuticals share count unchanged in Q1 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1978 holding.
- Ameritas Investment Partners first reported a position in Amphastar Pharmaceuticals in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Amphastar Pharmaceuticals position peaked at $247K in Q4 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.